Erythropoietic protoporphyria (EPP) is a rare genetic condition that makes skin intensely painful after exposure to sunlight and even some artificial light. It affects roughly 5 to 15 people per million worldwide, making it the most common of the porphyrias, a family of disorders involving the body’s production of heme, the iron-containing molecule in red blood cells. Symptoms usually begin in early childhood, and because the skin often looks normal during a reaction, the condition is frequently misdiagnosed or dismissed for years.
What Happens Inside the Body
Your body builds heme through an eight-step assembly line. The final step requires an enzyme called ferrochelatase, which attaches iron to a molecule called protoporphyrin IX. In EPP, a genetic mutation leaves this enzyme partially disabled. Without enough working ferrochelatase, protoporphyrin IX piles up in red blood cells and eventually spills into the bloodstream and skin. Normal protoporphyrin levels in red blood cells sit around 80 mcg/dL. In someone with EPP, levels range from 300 to 8,000 mcg/dL.
Protoporphyrin IX is a photosensitizer. When it absorbs light, it generates reactive oxygen species that damage surrounding tissue from the inside out. Critically, the wavelengths that trigger this reaction fall in the visible light range (400 to 700 nm), not just ultraviolet. This means standard sunscreens, which block UV rays, offer little to no protection. Regular window glass transmits up to 90% of visible light, so sitting near a window or riding in a car can cause a reaction.
EPP vs. X-Linked Protoporphyria
A closely related condition called X-linked protoporphyria (XLP) produces nearly identical symptoms but has a different genetic cause. While EPP stems from reduced ferrochelatase activity, XLP results from a gain-of-function mutation in a gene called ALAS2, which sits on the X chromosome. This mutation makes an earlier enzyme in the heme pathway overactive, flooding the system with protoporphyrin IX from the opposite direction. All males who carry the XLP mutation are affected, while females may range from completely asymptomatic to severely symptomatic depending on which X chromosome is active in their cells. Blood tests alone can’t always distinguish EPP from XLP, so genetic testing is recommended for anyone with elevated protoporphyrin levels.
What a Phototoxic Reaction Feels Like
People with EPP describe their reactions in visceral terms: being cut by knives, poked with hot pins, or having skin covered in boiling oil. The pain is real and intense, even when the skin shows little or no visible change. This invisible suffering is a hallmark of EPP and a major reason it goes unrecognized. Visible signs like redness and swelling, when they appear at all, typically lag behind the pain.
Nearly all patients notice prodromal warning symptoms before a full reaction develops. About two-thirds feel these warning signs within 30 minutes of sun exposure, usually tingling, itching, or a prickling sensation on exposed skin. If exposure continues, the reaction escalates to burning pain, swelling (especially on the hands and face), and deep achiness. Many patients also report fatigue and a generalized sense of illness during severe episodes. Cold temperatures provide noticeable relief, and it’s common for people with EPP to plunge their hands into ice water or press frozen objects against their skin during a flare.
Reactions can last hours to days. Because the damage is happening at a cellular level beneath the skin surface, there may be nothing visible for a doctor to examine, which contributes to the long diagnostic delays many patients experience.
How EPP Is Diagnosed
The key diagnostic test measures total protoporphyrin levels in red blood cells. In EPP, these levels are dramatically elevated, and the protoporphyrin is predominantly “metal-free” rather than bound to zinc. This distinction matters because zinc-bound protoporphyrin rises in other conditions like iron deficiency and lead poisoning. A blood sample showing high metal-free protoporphyrin strongly points toward EPP or XLP, and genetic sequencing of the ferrochelatase and ALAS2 genes confirms which one.
The average delay between first symptoms and diagnosis is often measured in years or even decades. Children who cry or scream during outdoor play, refuse to go outside, or instinctively hide their hands from light are sometimes labeled as having behavioral problems before anyone considers EPP. A family history of similar light sensitivity is a strong clue, though not always present.
Liver Complications
The excess protoporphyrin doesn’t just affect skin. It is cleared from the body through the liver and excreted in bile. Over time, protoporphyrin can accumulate in liver tissue and cause damage. Roughly 5% to 20% of people with EPP develop some degree of liver disease. Most cases are mild, showing up as slightly abnormal liver enzymes on blood tests. In rare but serious cases, protoporphyrin deposits can cause progressive liver damage that may eventually require transplantation.
There is no consensus on exactly how often liver function should be monitored. Some specialists recommend blood tests every six months, while others suggest annual testing through age 20 and then every two years. Liver biopsy remains the most accurate way to assess damage, since standard blood tests don’t always correlate well with the actual degree of injury.
Light Protection Strategies
Because visible light triggers EPP reactions, protection requires a different approach than typical sun safety. Conventional sunscreens block UV but let visible light pass through freely. Instead, people with EPP rely on physical barriers: tightly woven clothing, wide-brimmed hats, and gloves. For the face and hands, sunscreens containing large opaque pigments like iron oxide or titanium dioxide provide some visible light protection, though they can’t block it completely.
Windows are a particular challenge. Clear glass allows up to 90% of visible light through, so car rides and time near windows at home, school, or work can all trigger reactions. Tinted or reflective window films reduce visible light transmission, though U.S. federal standards require windshields to allow at least 70% of visible light through, limiting how much protection car windshield tinting can offer. Some patients apply for medical exemptions for darker window tinting on side and rear windows. Blue-tinted lenses can absorb some of the most reactive wavelengths (400 to 500 nm), but they don’t eliminate risk.
Treatment Options
For most of EPP’s history, there was no approved treatment. Patients simply avoided light. That changed with afamelanotide, a synthetic version of the hormone that signals skin cells to produce melanin. Delivered as a small implant placed under the skin, it stimulates melanin production throughout the body. The added melanin acts as an internal photoprotectant, absorbing some of the visible light before it can activate protoporphyrin IX. The implant also has antioxidant properties that help neutralize the reactive molecules generated during light exposure.
Clinical trials and observational studies show that patients treated with afamelanotide can tolerate significantly more sunlight with fewer and less severe phototoxic reactions. Quality of life improves substantially, with patients reporting their first pain-free time outdoors in years. The treatment is approved for adult EPP patients in Europe, the United States, and Australia. Patients typically receive multiple doses over time; in one long-term German study, patients received an average of about 11 doses over roughly four and a half years.
Afamelanotide does not cure EPP or lower protoporphyrin levels. It raises the threshold of light exposure the skin can tolerate, giving patients a larger window of time outdoors. An oral medication called dersimelagon works through a similar mechanism, activating the same melanin-producing receptor but taken as a pill rather than an implant. It has shown meaningful benefits in mid-stage clinical trials. A second oral drug, bitopertin, takes a different approach entirely: it restricts one of the raw ingredients cells need to make protoporphyrin IX in the first place, aiming to reduce production at the source. It is currently in mid-stage trials as well.
Living With EPP
EPP shapes daily life in ways that go far beyond avoiding the beach. Grocery store fluorescent lights, car rides on sunny days, classroom seats near windows, and outdoor school activities all become potential triggers. Children with EPP often struggle socially because they can’t participate in the same outdoor activities as their peers, and the invisible nature of their pain makes it hard for others to understand.
Seasonal patterns are pronounced. Spring and summer bring longer days and stronger light, and the incidence of reactions rises sharply. Many patients describe winter as their only season of relative freedom. Planning around weather forecasts, cloud cover, and time of day becomes second nature. Even on overcast days, enough visible light penetrates clouds to cause reactions in sensitive individuals.
The psychological burden is significant. Studies consistently show reduced quality of life, with isolation, anxiety about light exposure, and frustration from years of being told nothing is wrong. For families, getting a diagnosis is often described as both devastating and validating: it finally puts a name to suffering that may have been dismissed for years.